Clinical Trial Update: Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA) [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating subcutaneous tirzepatide once weekly in adults with obesity and knee osteoarthritis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis
• Obesity

Drugs mentioned

• Tirzepatide (tirzepatide)

Snippet

Sponsor: University of Melbourne | Conditions: Obesity, Knee Osteoarthritis | Phase 4 | Status: RECRUITING